Research / APPS / Fundamental state Inspectable configuration
State dimensions Filing 0001628280-26-053446 General Corporate
Debt relative to revenue 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
212.59% · OPTIONAL · VALID
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.02% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation 60th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
10.76% · OPTIONAL · VALID
Revenue growth 80th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
26.78% · CORE · VALID
Gross margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
57.20% · CORE · VALID
Operating margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
13.89% · CORE · VALID
R&D intensity 5th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
6.38% · OPTIONAL · VALID
SBC intensity 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
1.47% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 66 states Self-history eligible
Sep 30, 2021 7/7 normalized Amended as filed Dec 31, 2021 7/7 normalized Amended as filed Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 7/8 normalized Level 3 Jun 30, 2026 7/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 63.86%
Current 212.59%
Delta 148.73% Capex Intensity Decreased
Previous 5.42%
Current 4.02%
Delta -1.39% Cash Generation Increased
Previous 7.40%
Current 10.76%
Delta 3.36% Growth Increased
Previous 15.24%
Current 26.78%
Delta 11.54% Margin Increased
Previous 56.90%
Current 57.20%
Delta 0.30% Profitability Increased
Previous 6.02%
Current 13.89%
Delta 7.87% R And D Intensity Decreased
Previous 7.16%
Current 6.38%
Delta -0.78% Sbc Intensity Decreased
Previous 2.89%
Current 1.47%
Delta -1.42% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Mar 31, 2021
Similarity 92%
Compared 5 dimensions
Coverage 71% Growth 10.0 · Profitability 0.0 · Sbc Intensity 0.0 · Cash Generation 15.0 · R And D Intensity 5.0 Dec 31, 2025
Similarity 89%
Compared 7 dimensions
Coverage 100% Growth 20.0 · Margin 5.0 · Profitability 5.0 · Sbc Intensity 0.0 · Cash Generation 15.0 · R And D Intensity 10.0 · Balance Sheet Leverage 5.0 Mar 31, 2019
Similarity 88%
Compared 6 dimensions
Coverage 86% Growth 10.0 · Margin 0.0 · Profitability 0.0 · Sbc Intensity 5.0 · Cash Generation 25.0 · R And D Intensity 10.0 Jun 30, 2020
Similarity 86%
Compared 6 dimensions
Coverage 86% Growth 0.0 · Margin 5.0 · Profitability 5.0 · Sbc Intensity 25.0 · Cash Generation 20.0 · R And D Intensity 5.0 Sep 30, 2019
Similarity 79%
Compared 6 dimensions
Coverage 86% Growth 15.0 · Margin 0.0 · Profitability 0.0 · Sbc Intensity 30.0 · Cash Generation 40.0 · R And D Intensity 0.0 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.